Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FYSIOVEJEN AUTORISEREDE FYSIOTERAPEUTER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   4.3% 3.0% 2.8% 2.9% 2.4% 2.2% 21.1% 21.1%   Credit score (0-100)   49 59 59 57 64 64 5 5   Credit rating   BBB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,222 2,032 1,865 2,101 2,215 2,419 0.0 0.0   EBITDA   562 469 432 484 523 594 0.0 0.0   EBIT   561 463 417 475 507 553 0.0 0.0   Pre-tax profit (PTP)   562.7 461.7 412.9 468.5 467.4 448.3 0.0 0.0   Net earnings   438.5 359.9 321.9 365.2 361.7 342.6 0.0 0.0   Pre-tax profit without non-rec. items   563 462 413 469 467 448 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   21.8 32.2 17.9 8.0 2,344 2,303 0.0 0.0   Shareholders equity total   564 486 448 491 487 470 4.6 4.6   Interest-bearing liabilities   1.3 1.3 19.9 0.0 1,903 1,797 0.0 0.0   Balance sheet total (assets)   895 807 961 901 2,639 2,580 4.6 4.6   Net Debt   -474 -464 -518 -543 1,900 1,792 -4.6 -4.6     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,222 2,032 1,865 2,101 2,215 2,419 0.0 0.0   Gross profit growth   8.5% -8.6% -8.2% 12.7% 5.4% 9.2% -100.0% 0.0%   Employees   4 4 4 4 5 4 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 25.0% -20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   895 807 961 901 2,639 2,580 5 5   Balance sheet change%   -1.8% -9.9% 19.1% -6.2% 192.8% -2.2% -99.8% 0.0%   Added value   561.6 469.1 431.6 484.4 516.9 594.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   22 4 -29 -20 2,320 -83 -2,303 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   25.3% 22.8% 22.4% 22.6% 22.9% 22.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   62.4% 54.4% 47.2% 51.0% 28.6% 21.2% 0.0% 0.0%   ROI %   98.1% 86.4% 82.8% 92.0% 34.7% 23.7% 0.0% 0.0%   ROE %   76.5% 68.5% 68.9% 77.7% 73.9% 71.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   63.0% 60.3% 46.6% 54.5% 18.5% 18.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -84.4% -98.9% -119.9% -112.0% 363.2% 301.6% 0.0% 0.0%   Gearing %   0.2% 0.3% 4.4% 0.0% 390.7% 382.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   70.2% 91.7% 41.7% 61.3% 4.2% 5.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.3 2.1 1.7 2.0 0.4 0.3 0.0 0.0   Current Ratio   2.4 2.3 1.8 2.1 0.4 0.4 0.0 0.0   Cash and cash equivalent   475.0 465.2 537.5 542.6 3.0 5.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   448.8 378.3 371.5 427.1 -338.2 -399.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   140 117 108 121 103 149 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   140 117 108 121 105 149 0 0   EBIT / employee   140 116 104 119 101 138 0 0   Net earnings / employee   110 90 80 91 72 86 0 0